AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work-and powered by our 22,000 associates-we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500, with more than $185 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries.
Financial Statements
- Click here to download Amerisource Bergen Corp.'s Income Statement
- Click here to download Amerisource Bergen Corp.'s Balance Sheet
- Click here to download Amerisource Bergen Corp.'s Statement of Cash Flows
Key Info
- Industry: Drugs and Druggists' Sundries Merchant Wholesalers
- Sector: Wholesale Trade
- CEO Name: Steven Collis
Key Statistics
- Stock Price: $170.15
- Dividend Yield: 1.0999999999999999%
- Market Capitalization: $33,611,381,324
- Shares Outstanding: 202,466,004
- Number of Employees: 44,000
- Trailing 12-Month EPS: $7.77
- Trailing 12-Month DPS: $1.9
- Payout Ratio: 24.5%
Important Dates
- Next Earnings Date: 2023-08-02
- Next Ex-Dividend Date: 2023-05-11
Price Trends
- Current Stock Price: $170.15
- 52-week high: $176.62
- 52-week low: $133.51
- 200-day moving average: $162.72
- 50-day moving average: $168.63
Performance
- 1-Month Price Return: -0.2%
- 3-Month Price Return: 6.3%
- 6-Month Price Return: -0.5%
- 1-Year Price Return: 7.5%
- 2-Year Price Return: 48.9%
- 5-Year Price Return: 114.3%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast